不依赖骨密度(BMD)的骨折风险评估工具(FRAX)可用于对近期发生低创伤非椎体/非髋部骨折的退伍军人进行风险分层
本研究利用杜勒姆退伍军人事务医疗中心骨折联络服务临床数据库,纳入229例年龄≥50岁、2013年10月至2018年4月间发生低创伤非髋部/非椎体骨折并接受双能X线吸收测定(DXA)的退伍军人,比较不依赖BMD的FRAX(FRAX-BMI)与依赖BMD的FRAX(FRAX-BMD)在预测美国国家骨质疏松基金会(NOF)指南治疗阈值达标情况上的一致性。结果显示FRAX-BMI预测治疗建议的一致性为75.6%,敏感度67.3%,特异度78.2%。作者结论认为FRAX-BMI可用于风险分层,识别可无需DXA即治疗的高危患者、可能无需治疗的低危患者以及需接受DXA检查的中危患者。
要点
- 在229例近期低创伤非髋部/非椎体骨折的退伍军人中,FRAX-BMI预测NOF指南治疗建议的一致性为75.6%。
- FRAX-BMI预测治疗建议的敏感度为67.3%,特异度为78.2%。
- FRAX-BMI髋部骨折风险的曲线下面积(AUC)为0.79。
核心结论
- 在发生低创伤非髋部/非椎体骨折的患者中,FRAX-BMI可用于风险分层,并识别可无需DXA即治疗的高危患者、可能无需治疗的低危患者以及需接受DXA检查的中危患者。
研究设计与样本
- 利用杜勒姆退伍军人事务医疗中心骨折联络服务建立的临床数据库,识别年龄≥50岁、发生低创伤非髋部/非椎体骨折并于2013年10月至2018年4月期间接受DXA的男性和女性退伍军人,共纳入229例患者。
- 对229例患者计算FRAX-BMI和FRAX-BMD,并比较其是否达到NOF指南治疗阈值。
主要发现
- 55例(24.0%)患者基于NOF指南确立的FRAX-BMD阈值达到治疗标准,其中27例(11.8%)经DXA诊断为骨质疏松。
- FRAX-BMI预测治疗建议的一致性为75.6%,敏感度为67.3%,特异度为78.2%。
- FRAX-BMI髋部骨折风险的AUC为0.79。
- 提出髋部骨折风险的评估/治疗阈值1%<FRAX-BMI<4%以最大化敏感度和特异度。
关键数值与推荐
- NOF指南治疗阈值:基于FRAX-BMD,55例(24.0%)达到治疗标准。
- FRAX-BMI预测治疗建议的一致性75.6%,敏感度67.3%,特异度78.2%。
- FRAX-BMI髋部骨折风险的AUC为0.79。
- 提出的髋部骨折风险评估/治疗阈值为1%<FRAX-BMI<4%。
临床怎么用
- 作者认为,对于发生低创伤非髋部/非椎体骨折的患者,FRAX-BMI可用于风险分层:识别可无需DXA即治疗的高危患者、可能无需治疗的低危患者,以及需接受DXA检查的中危患者。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: We evaluated the fracture risk assessment tool (FRAX) without bone mineral density (BMD) in predicting treatment recommendations for patients with a recent low trauma fracture other than hip or vertebral. The concordance, sensitivity, and specificity were 75.6%, 67.3%, and 78.2%, respectively. FRAX without BMD can be used after a fracture to expedite treatment. INTRODUCTION: The objective of this study was to evaluate the performance of the fracture risk assessment tool (FRAX) without bone mineral density (BMD) in predicting treatment recommendations for patients who recently sustained a low trauma fracture other than hip or vertebral. METHODS: We utilized a clinical database established by the Fracture Liaison Service at the Durham Veterans Affairs Medical Center to identify male and female Veterans age ≥ 50 years who sustained a low trauma non-hip/non-vertebral fracture and underwent dual-energy x-ray absorptiometry (DXA) between October 2013 and April 2018. FRAX without BMD (FRAX-BMI) and FRAX with BMD (FRAX-BMD) were calculated for the 229 patients identified, and whether or not they met the National Osteoporosis Foundation (NOF) guideline treatment thresholds was compared. RESULTS: There were 55 (24.0%) patients that met criteria for treatment based on NOF guideline established FRAX-BMD thresholds including 27 (11.8%) patients with osteoporosis by DXA. The concordance of FRAX-BMI in predicting treatment recommendations was 75.6% with a sensitivity of 67.3% and a specificity of 78.2%. The area under the curve (AUC) of FRAX-BMI hip fracture risk was 0.79. Assessment/treatment thresholds for hip fracture risk of 1% < FRAX-BMI < 4% were proposed to maximize sensitivity and specificity. CONCLUSION: Among patients who sustained a low trauma non-hip/non-vertebral fracture, FRAX-BMI can be used to stratify risk and identify high-risk patients who could be treated without DXA, low-risk patients who may not need treatment, and intermediate-risk patients to undergo DXA testing.
引用
- Sagalla N, Colón-Emeric C, Sloane R, et al. FRAX without BMD can be used to risk-stratify Veterans who recently sustained a low trauma non-vertebral/non-hip fracture. Osteoporos Int. 2020. PMID: 32885318. doi:10.1007/s00198-020-05616-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。